Market and Product Forecasts: Prostate Cancer
Four new product launches in prostate cancer over the next 10 years, including
Medivation’s androgen receptor inhibitor MDV3100 and Takeda’s 17, 20 lyase inhibitor
TAK-700 will counter generic erosion. In addition Increasing use of Zytiga (abiraterone;
Johnson&Johnson) and Jevtana (cabazitaxel;Sanofi) will boost market value from $1.7bn
in 2011 to $4.3bn by 2020.
Features and benefits
Access Datamonitor’s patient based prostate cancer market forecast for the seven major
markets, with transparent methodology and clear assumptions.
See how each new product launch will impact the market, and where the strongest
competition lies.
Gain insight into prostate cancer market dynamics, and see where market potential
remains.
Request a Sample for or Inquire before buying the report @ Prostate Cancer
Market
Datamonitor forecasts sales for prostate cancer to reach $1.7bn in 2011 in the seven
major markets, growing to $4.3bn by 2020, representing a positive 2011-2020 CAGR of
8%. However, Datamonitor’s survey of 124 medical oncologists and urologists suggests
that high levels of unmet need remain in preventing the emergence of castration
resistance.
Datamonitor estimates that in 2011 the antihormonal class of drugs dominated the
prostate cancer market with 63% market share, owing to wide use in both clinically
localized and advanced disease. Zytiga is set to become market leader with market share
peaking at 18% before patent expiry
Major points covered in Table of Contents of this report include:
OVERVIEW
EXECUTIVE SUMMARY
MARKET DEFINITION
MARKET OVERVIEW AND CONTEXT
PRODUCT FORECASTS
BIBLIOGRAPHY
APPENDIX
List Of Tables
List Of Figures
Explore Comprehensive list of Tables & Figures available in the report @
http://www.reportsnreports.com/reports/144315-market-and-product-forecasts-
prostate-cancer.html
Report Details:
Published: December 2011
No. of Pages: 58
Price: Single User License – US$11400 Corporate User License – US$28500
Contact:
Priyank Tiwari
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-391-5441
sales@reportsandreports.com
Visit our Market Research Blog @ http://www.reportsnreportsblog.com/
Connect With Us: